References

Pattern recognition receptors: function, regulation and therapeutic potential

10.1038/s41392-025-02264-1 · 2025 · External reference

Immune and inflammatory-mediated disorders: From bench to bedside

10.1155/2018/7197931 · 2018 · External reference

Editorial: Innate immune dysregulation: a driving force of autoimmunity and chronic inflammation

10.3389/fimmu.2025.1632416 · 2025 · External reference

Epigenetic modulations of immune cells: from normal development to tumor progression

10.7150/ijbs.88327 · 2023 · External reference

Epigenomic control of immunity: from mechanisms to therapeutic targets in inflammatory bowel diseases

10.1093/intimm/dxaf039 · 2025 · External reference

miRNA–lncRNA cross-regulation landscape in cancer: from molecular mechanisms to therapeutic and diagnostic applications

10.3390/cancers18101610 · 2026 · External reference

MicroRNAs in stress signaling and human disease

10.1016/j.cell.2012.02.005 · 2012 · External reference

The power of microRNA regulation-insights into immunity and metabolism

10.1002/1873-3468.70039 · 2025 · External reference

Role of microRNAs in immune regulation with translational and clinical applications

10.3390/ijms25031942 · 2024 · External reference

MicroRNAs in human diseases: from autoimmune diseases to skin, psychiatric and neurodegenerative diseases

10.4110/in.2011.11.5.227 · 2011 · External reference

miRNAs alter T helper 17 cell fate in the pathogenesis of autoimmune diseases

10.3389/fimmu.2021.593473 · 2021 · External reference

The mechanistic review of the molecular interface of RNA-loaded extracellular vesicles: redefining targeted therapy for autoimmune disorders

10.3390/ijms27104323 · 2026 · External reference

MicroRNA history: discovery, recent applications, and next frontiers

10.1016/j.mrfmmm.2011.03.009 · 2011 · External reference

The involvement of microRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis

10.1155/2018/4126106 · 2018 · External reference

Regulatory roles of microRNA in shaping T cell function, differentiation and polarization

10.1016/j.semcdb.2021.08.003 · 2022 · External reference

MicroRNAs in the diagnosis of digestive diseases: a comprehensive review

10.3390/jcm14062054 · 2025 · External reference

Overview of microRNA biogenesis, mechanisms of actions, and circulation

10.3389/fendo.2018.00402 · 2018 · External reference

The microRNA (miRNA): overview of the RNA genes that modulate gene function

10.1007/s12033-007-9013-8 · 2008 · External reference

The Drosha-DGCR8 complex in primary microRNA processing

10.1101/gad.1262504 · 2004 · External reference

Regulation of microRNA biogenesis

10.1038/nrm3838 · 2014 · External reference

MicroRNAs and immune-related disorders

10.1007/978-3-031-64788-8_8 · 2024 · External reference

Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis

10.1002/art.23386 · 2008 · External reference

A polymorphism in the 3-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility

10.1016/j.jbspin.2010.05.013 · 2010 · External reference

Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis

10.1186/ar3006 · 2010 · External reference

Bruton’s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes

10.4049/jimmunol.0801613 · 2009 · External reference

miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization

10.1371/journal.pone.0019827 · 2011 · External reference

MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis

10.1002/art.24475 · 2009 · External reference

Down‐regulation of microRNA‐34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance

10.1002/art.34334 · 2012 · External reference

miR-143-3p regulates cell proliferation and apoptosis by targeting IGF1R and IGFBP5 and regulating the Ras/p38 MAPK signaling pathway in rheumatoid arthritis

10.3892/etm.2018.5907 · 2018 · External reference

miR-338-5p regulates the viability, proliferation, apoptosis and migration of rheumatoid arthritis fibroblast-like synoviocytes by targeting NFAT5

10.1159/000493222 · 2018 · External reference

MicroRNA-192 suppresses cell proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes by downregulating caveolin 1

10.1007/s11010-017-3003-3 · 2017 · External reference

MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis

10.1016/j.jaci.2016.07.025 · 2017 · External reference

Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions

10.1016/j.imlet.2012.09.004 · 2012 · External reference

Rapid and widespread suppression of self-renewal by microRNA-203 during epidermal differentiation

10.1242/dev.089649 · 2013 · External reference

MiR-203 promotes HaCaT cell overproliferation through targeting LXR-a and PPAR-g

10.1080/15384101.2020.1783934 · 2020 · External reference

Circulating microRNA203 and its target genes' role in psoriasis pathogenesis

10.3389/fmed.2022.988962 · 2022 · External reference

LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8

10.1186/s12860-019-0229-9 · 2019 · External reference

MicroRNA biomarkers in psoriasis

10.1016/j.cca.2025.120633 · 2025 · External reference

Understanding psoriasis: Role of miRNAs

10.3892/br.2018.1146 · 2018 · External reference

MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40

10.4049/jimmunol.1202695 · 2013 · External reference

MiR-99a inhibits keratinocyte proliferation by targeting Frizzled-5 (FZD5) / FZD8 through b-catenin signaling in psoriasis

10.1691/ph.2017.7018 · 2017 · External reference

MiR-125b-mediated regulation of cell proliferation through the Jagged-1/Notch signaling pathway by inhibiting BRD4 expression in psoriasis

10.3892/mmr.2019.10187 · 2019 · External reference

MiR-155 promotes cell proliferation and inhibits apoptosis by PTEN signaling pathway in the psoriasis

10.1016/j.biopha.2017.03.105 · 2017 · External reference

Differential micro RNA expression in PBMC from multiple sclerosis patients

10.1371/journal.pone.0006309 · 2009 · External reference

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

10.1038/ni.1798 · 2009 · External reference

Relationship between miRNA-21, miRNA-155, and miRNA-182 expression and inflammatory factors in cerebrospinal fluid from patients with multiple sclerosis

10.1016/j.clineuro.2023.107873 · 2023 · External reference

MiRNA-467b inhibits Th17 differentiation by targeting eIF4E in experimental autoimmune encephalomyelitis

10.1016/j.molimm.2021.02.008 · 2021 · External reference

MicroRNAs and multiple sclerosis

10.4061/2011/807426 · 2011 · External reference

The role of miRNA in inflammation and autoimmunity

10.1016/j.autrev.2013.07.003 · 2013 · External reference

Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing- remitting multiple sclerosis patients

10.1002/eji.200940032 · 2010 · External reference

MicroRNA-21 and microRNA- 148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1

10.4049/jimmunol.0904060 · 2010 · External reference

Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression

10.1136/ard.2010.139857 · 2011 · External reference

MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1

10.1016/j.jdermsci.2012.10.011 · 2013 · External reference

MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1

10.1002/art.30196 · 2011 · External reference

Expression signature of microRNA-181-areveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus

2011 · External reference

The role of miR-146a in modulating TRAF6-induced inflammation during lupus nephritis

2017 · External reference

MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus

10.1002/art.27632 · 2010 · External reference

Dicer insufficiency and MicroRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu

10.4049/jimmunol.1002218 · 2011 · External reference

Deletion of microRNA-183-96-182 cluster in lymphocytes suppresses Anti-DsDNA autoantibody production and IgG deposition in the kidneys in C57BL/6-Faslpr/lpr Mice

10.3389/fgene.2022.840060 · 2022 · External reference

Microarray analysis of micro- RNA expression in peripheral blood cells of systemic lupus erythematosus patients

10.1177/0961203307084158 · 2007 · External reference

The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus

10.1186/s13148-015-0063-7 · 2015 · External reference

Excessive miR-152-3p results in increased BAFF expression in SLE B-cells by inhibiting the KLF5 expression

10.3389/fimmu.2019.01127 · 2019 · External reference

MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2α

10.1053/j.gastro.2008.07.068 · 2008 · External reference

NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells

10.1097/01.mib.0000436954.70596.9b · 2014 · External reference

Downregulation of MicroRNA-21 in colonic CD3+ T cells in UC remission

10.1097/mib.0000000000000969 · 2016 · External reference

Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB

10.1016/j.bbrc.2013.03.122 · 2013 · External reference

MicroRNA-31 and MicroRNA-155 are overexpressed in ulcerative colitis and regulate IL-13 signaling by targeting interleukin 13 receptor α-1

10.3390/genes9020085 · 2018 · External reference

The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release

10.1016/j.immuni.2013.08.035 · 2013 · External reference

MicroRNA regulation of intestinal epithelial tight junction permeability

10.1053/j.gastro.2011.07.005 · 2011 · External reference

MicroRNA-141 is involved in ulcerative colitis pathogenesis via aiming at CXCL5

10.1089/jir.2017.0019 · 2017 · External reference

miR-141 regulates colonic leukocytic trafficking by targeting CXCL12 during murine colitis and human Crohn’s disease

10.1136/gutjnl-2012-304213 · 2014 · External reference

Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis

10.1002/path.2907 · 2011 · External reference

MicroRNA-124 alleviates chronic skin inflammation in atopic eczema via suppressing innate immune responses in keratinocytes

10.1016/j.cellimm.2017.08.003 · 2017 · External reference

MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1

10.1007/s11010-016-2696-z · 2016 · External reference

MiR‐151a is involved in the pathogenesis of atopic dermatitis by regulating interleukin‐12 receptor β2

10.1111/exd.13276 · 2018 · External reference

MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 (Th17) cells

10.1111/cei.12624 · 2015 · External reference

Belinostat resolves skin barrier defects in atopic dermatitis by targeting the dysregulated miR-335: SOX6 axis

10.1016/j.jaci.2020.02.007 · 2020 · External reference

Rheumatoid arthritis: pathogenesis and therapeutic advances

10.1002/mco2.509 · 2024 · External reference

Role of miRNAs in rheumatoid arthritis therapy

10.3390/cells12131749 · 2023 · External reference

The pathogenesis of rheumatoid arthritis: breakthroughs in molecular mechanisms

10.3390/ijms241311060 · 2023 · External reference

Global epidemiology of rheumatoid arthritis

10.1038/s41584-022-00827-y · 2022 · External reference

MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy

10.2165/11631480-000000000-00000 · 2012 · External reference

The emerging role of circulating microRNAs as biomarkers in autoimmune diseases

10.3109/08916934.2014.929667 · 2014 · External reference

microRNAs as biomarkers and therapeutic targets in rheumatoid arthritis

10.3390/ijms26209950 · 2025 · External reference

MicroRNAs: emerging regulators of immune‐mediated diseases

10.1111/j.1365-3083.2011.02650.x · 2012 · External reference

MicroRNAs as new player in rheumatoid arthritis

10.1016/j.jbspin.2010.06.003 · 2011 · External reference

IL-10 inhibits miR-155 induction by Toll-like receptors

10.1074/jbc.m110.102111 · 2010 · External reference

Role of synovial fibroblasts in rheumatoid arthritis

10.2174/1381612820666140825122036 · 2015 · External reference

Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis

10.1186/ar3013 · 2010 · External reference

Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis

10.1371/journal.pone.0069118 · 2013 · External reference

Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis

10.1080/09674845.2017.1343545 · 2017 · External reference

A study of miRNA 223 expression and its correlation with disease severity in chronic plaque psoriasis

10.4103/ijd.ijd_305_23 · 2023 · External reference

Circulating microRNA associated with TNF-α signaling pathway in patients with plaque psoriasis

10.1016/j.jdermsci.2010.12.008 · 2011 · External reference

Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity

10.1684/ejd.2013.2148 · 2013 · External reference

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

10.1016/j.jdermsci.2014.05.005 · 2014 · External reference

Differential microRNA expression in blood in multiple sclerosis

10.1177/1352458513490542 · 2013 · External reference

Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS

10.1186/s12974-017-1006-3 · 2017 · External reference

Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis

10.1177/1352458513485654 · 2013 · External reference

miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands

10.1177/1352458516684213 · 2017 · External reference

miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing–remitting multiple sclerosis

10.1016/j.gene.2014.04.069 · 2014 · External reference

Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study

10.1212/wnl.0b013e3182759621 · 2012 · External reference

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis

10.1212/nxi.0000000000000219 · 2016 · External reference

Circulating miR‐181a and miR‐223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis

10.1002/jgm.3326 · 2021 · External reference

Novel microRNA biomarkers of systemic lupus erythematosus in plasma: miR-124-3p and miR-377-3p

10.1016/j.clinbiochem.2022.05.004 · 2022 · External reference

Serum miRNA-371b-5p and miRNA-5100 act as biomarkers for systemic lupus erythematosus

10.1016/j.clim.2018.10.004 · 2018 · External reference

miR‐183‐5p is a potential molecular marker of systemic lupus erythematosus

10.1155/2021/5547635 · 2021 · External reference

Serum and urinary cell–free MiR-146a and MiR-155 in patients with systemic lupus erythematosus

10.3899/jrheum.100308 · 2010 · External reference

Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity

10.1038/modpathol.2013.152 · 2014 · External reference

Circulating microRNA146b‐5p is superior to C‐reactive protein as a novel biomarker for monitoring inflammatory bowel disease

10.1111/apt.15159 · 2019 · External reference

Circulating microRNAs as biomarkers of adult Crohn’s disease

10.1097/meg.0000000000000430 · 2015 · External reference

Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon

10.1016/j.crohns.2014.02.012 · 2014 · External reference

Plasma miR223 is a possible biomarker for diagnosing patients with severe atopic dermatitis

10.1016/j.alit.2020.07.010 · 2021 · External reference

MicroRNA analysis of childhood atopic dermatitis reveals a role for miR‐451a

10.1111/bjd.19254 · 2021 · External reference

Possible role of hsa-miR-194-5p, via regulation of HS3ST2, in the pathogenesis of atopic dermatitis in children

10.1684/ejd.2019.3676 · 2019 · External reference

The role of microRNA in psoriasis: a review

10.1111/exd.14871 · 2023 · External reference

Psoriasis treatments: emerging roles and future prospects of micrornas

10.3390/ncrna11010016 · 2025 · External reference

Insightful exploring of microRNAs in psoriasis and its targeted topical delivery

10.1111/dth.14221 · 2020 · External reference

miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis

10.1016/j.jid.2017.05.012 · 2017 · External reference

microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris

10.1111/j.1365-2133.2011.10497.x · 2011 · External reference

Protein KINASE C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes

10.1038/jid.2009.294 · 2010 · External reference

MiRNAs flowing up and down: The concerto of psoriasis

10.3389/fmed.2021.646796 · 2021 · External reference

Expression levels of lncRNA NEAT1, miRNA-21, and IL-17 in a group of Egyptian patients with Behçet’s disease: relation to disease manifestations and activity

10.2147/btt.s493191 · 2024 · External reference

Targeting TGF-β1/miR-21 pathway in keratinocytes reveals protective effects of silymarin on imiquimod-induced psoriasis mouse model

10.1016/j.xjidi.2022.100175 · 2023 · External reference

MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R

10.1371/journal.pone.0020916 · 2011 · External reference

The crosstalk between IL-22 signaling and miR-197 in human keratinocytes

10.1371/journal.pone.0107467 · 2014 · External reference

Multiple sclerosis: roles of miRNA, lcnRNA, and circRNA and their implications in cellular pathways

10.3390/ijms25042255 · 2024 · External reference

MicroRNA in multiple sclerosis

10.1016/j.cca.2021.01.020 · 2021 · External reference

The role of microRNAs in multiple sclerosis

10.1080/08830185.2020.1826474 · 2022 · External reference

WNT signalling in theimmune system: WNT is spreading its wings

10.1038/nri2360 · 2008 · External reference

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

10.1158/0008-5472.can-08-1768 · 2008 · External reference

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

10.1016/j.jneuroim.2010.06.009 · 2010 · External reference

Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study

10.1186/s12883-022-02909-6 · 2022 · External reference

The circRNA–miRNA–mRNA regulatory network in systemic lupus erythematosus

10.1007/s10067-020-05212-2 · 2021 · External reference

Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus

10.3389/fimmu.2022.1059887 · 2022 · External reference

Serum andurinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus

10.3899/jrheum.100308 · 2010 · External reference

Analysis of microRNA-199a-3p expression in CD4+ T cells of systemic lupus erythematosus

10.1007/s10067-023-06534-7 · 2023 · External reference

MicroRNA-183/96/182 cluster in immunity and autoimmunity

10.3389/fimmu.2023.1134634 · 2023 · External reference

MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy

10.1007/s10238-023-01234-7 · 2023 · External reference

MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus

10.1371/journal.pgen.1003336 · 2013 · External reference

MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus

10.1016/j.cbi.2016.11.001 · 2016 · External reference

Dysregulated microRNAs in the pathogenesis of systemic lupus erythematosus: a comprehensive review

10.7150/ijbs.74315 · 2023 · External reference

Roles of microRNAs in inflammatory bowel disease

10.7150/ijbs.59904 · 2021 · External reference

MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease

10.1007/s10238-024-01476-z · 2024 · External reference

miRNA molecules—late breaking treatment for inflammatory bowel diseases

10.3390/ijms24032233 · 2023 · External reference

MicroRNAs as innovative biomarkers for inflammatory bowel disease and prediction of colorectal cancer

10.3390/ijms23147991 · 2022 · External reference

MicroRNAs in inflammatory bowel disease and its complications

10.3390/ijms23158751 · 2022 · External reference

Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease

10.1371/journal.pone.0044156 · 2012 · External reference

The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17- mediated inflammation response in colitis

10.1038/mi.2016.102 · 2017 · External reference

Elevated miRNA inversely correlates with E-cadherin gene expression in tissue biopsies from Crohn disease patients in contrast to ulcerative colitis patients

10.1155/2020/4250329 · 2020 · External reference

In Crohn’s disease fibrosis-reduced expression of the miR-29 family enhances collagen expression in intestinal fibroblasts

10.1042/cs20140048 · 2014 · External reference

Intestinal fibrosis in Crohn’s disease: Role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets

10.1097/mib.0000000000000298 · 2015 · External reference

Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease

10.1152/ajpgi.00268.2017 · 2018 · External reference

NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease

10.1074/jbc.m113.492496 · 2013 · External reference

Current understanding of epigenetics in atopic dermatitis

10.1111/exd.14392 · 2021 · External reference

The role of microRNA in the pathogenesis of atopic dermatitis

10.3390/ijms26125846 · 2025 · External reference

The essential role of micrornas in inflammatory and autoimmune skin diseases—a review

10.3390/ijms24119130 · 2023 · External reference

miR‐10a‐5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation

10.1111/all.13849 · 2019 · External reference

IFN-γ-induced microRNA-29b up-regulation contributes tokeratinocyte apoptosis in atopic dermatitis through inhibiting Bcl2L2

2017 · External reference

miR‐146a attenuates inflammatory pathways mediated by TLR4/NF‐κB and TNFα to protect primary human retinal microvascular endothelial cells grown in high glucose

10.1155/2016/3958453 · 2016 · External reference

Increased plasma miR-24 and miR-191 levels in patients with severe atopic dermatitis: Possible involvement of platelet activation

10.1016/j.clim.2022.108983 · 2022 · External reference

Expression of miRNA 155, FOXP3 and ROR gamma, in children with moderate and severe atopic dermatitis

10.23736/s0392-0488.17.05707-8 · 2017 · External reference

The potency of lncRNA MALAT1/miR-155/CTLA4 axis in altering Th1/Th2 balance of asthma

10.1042/bsr20190397 · 2020 · External reference

Requirement of bic/microRNA-155 for normal immune function

10.1126/science.1139253 · 2007 · External reference

MiR-1294 suppresses ROS-dependent inflammatory response in atopic dermatitis via restraining STAT3/NF-κB pathway

10.1016/j.cellimm.2021.104452 · 2022 · External reference

MicroRNAs: from junk RNA to life regulators and their role in cardiovascular disease

10.3390/cardiogenetics11040023 · 2021 · External reference

Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders

10.1016/j.jaut.2020.102472 · 2020 · External reference

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls

10.1371/journal.pone.0007440 · 2009 · External reference

MicroRNAs and their neuroimmunoregulator mechanisms in multiple sclerosis. Development of biomarkers for diagnosis

10.33588/rn.6012.2014357 · 2015 · External reference

Exosomal microRNA signatures in multiple sclerosis reflect disease status

10.1038/s41598-017-14301-3 · 2017 · External reference

MicroRNA 26a expression in peripheral blood mononuclear cells and correlation with serum interleukin-17 in relapsing-remitting multiple sclerosis patients

2017 · External reference

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis

10.1002/ana.23880 · 2013 · External reference

Promising roles of exosomal microRNAs in systemic lupus erythematosus

10.3389/fimmu.2021.757096 · 2021 · External reference

Serum and urinary free microRNA level in patients with systemic lupus erythematosus

10.1177/0961203310389841 · 2011 · External reference

Circulating and faecal micrornas as non-invasive biomarkers for ibd: current evidence and next steps

10.1016/j.bpg.2025.102064 · 2025 · External reference

Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases

10.1093/ibd/izy046 · 2018 · External reference

Circulating MicroRNA in inflammatory bowel disease

10.1016/j.crohns.2012.02.006 · 2012 · External reference

Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease

10.1111/cei.12104 · 2013 · External reference

MicroRNAs classify different disease behavior phenotypes of Crohn’s disease and may have prognostic utility

10.1097/mib.0000000000000478 · 2015 · External reference

Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis

10.1371/journal.pone.0031241 · 2012 · External reference

MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis

10.1186/s12865-015-0069-0 · 2015 · External reference

MicroRNA-146a as a potential regulator involved in the pathogenesis of atopic dermatitis

10.3892/mmr.2019.10695 · 2019 · External reference

miRNA-146-a, miRNA-21, miRNA-143, miRNA-29-b and miRNA-223 as Potential Biomarkers for Atopic Dermatitis

10.3390/clinpract15110192 · 2025 · External reference

The role of microRNAs in inflammatory bowel disease

10.3390/ijms26104750 · 2025 · External reference

Anti-inflammatory microRNAs for treating inflammatory skin diseases

10.3390/biom12081072 · 2022 · External reference

Regulatory roles of microRNAs in epigenetic and immune gene networks in psoriasis

10.1016/j.gene.2026.150081 · 2026 · External reference

miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis

10.1136/ard.2010.138669 · 2011 · External reference

Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of microRNAs 140‐3p and 140‐5p

10.1002/art.39446 · 2016 · External reference

miRNAs and exosomes in psoriasis: coordinating cytoskeleton dynamics and extracellular matrix remodeling

10.3389/fcell.2025.1608902 · 2025 · External reference

miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells

10.1111/ajco.13602 · 2022 · External reference

TargetingmiR-21 to treat psoriasis

10.1126/scitranslmed.3008089 · 2014 · External reference

miR‐205‐5p inhibits psoriasis‐associated proliferation and angiogenesis: Wnt/β‐catenin and mitogen‐activated protein kinase signaling pathway are involved

10.1111/1346-8138.15370 · 2020 · External reference

miR-340 alleviates psoriasis in micethrough direct targeting of IL-17A

10.4049/jimmunol.1800189 · 2018 · External reference

Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis

10.1111/bjd.17256 · 2019 · External reference

Dysregulated microRNA involvement in multiple sclerosis by induction of T helper 17 cell differentiation

10.3389/fimmu.2018.01256 · 2018 · External reference

MicroRNA-15b suppresses Th17 differentiation and is associated with pathogenesis of multiple sclerosis by targeting O-GlcNAc transferase

10.4049/jimmunol.1601727 · 2017 · External reference

Downregulation of microRNA-101- 3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9

10.1002/jcb.29624 · 2020 · External reference

MicroRNA-590-3p inhibits T helper 17 cells and ameliorates inflammation in lupus mice

10.1111/imm.13434 · 2022 · External reference

Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development

10.1016/j.jaut.2020.102440 · 2020 · External reference

miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD

10.1136/gutjnl-2015-309389 · 2016 · External reference

Crohn’s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy

10.1053/j.gastro.2013.10.021 · 2014 · External reference

MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis

10.1038/emm.2015.21 · 2015 · External reference

JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases

10.3389/fmed.2023.1089099 · 2023 · External reference

Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease

10.1186/s13059-016-0901-8 · 2016 · External reference

Protection by microRNA-7a-5p antagomir against intestinal mucosal injury related to the JNK pathway in TNBS-induced experimental colitis

10.5152/tjg.2021.20746 · 2021 · External reference

MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis

10.18632/aging.103555 · 2020 · External reference

The role of microRNAs in atopic dermatitis

10.1016/j.ncrna.2024.05.012 · 2024 · External reference

MicroRNAs in several cutaneous autoimmune diseases: psoriasis, cutaneous lupus erythematosus and atopic dermatitis

10.3390/cells9122656 · 2020 · External reference

IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B

10.1016/j.jaci.2019.12.905 · 2020 · External reference